allergic conjunctivitis
Conditions
Interventions
Western medicine group:Potassium pyrimethamine eye drops combined with fluticasone eye drops
Acupuncture-medicine combination group:intranasal needling combined with pyrimethamine potassium eye drops
Sponsors
Dongzhimen Hospital Beijing University of Chinese Medicine China
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the clinical diagnostic criteria for allergic conjunctivitis and be 18-70 years of age; (2) Being in an episode of conjunctivitis; (3) Subjects voluntarily accept the appropriate trial protocol accept timely follow-up and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Concomitant ocular surface diseases such as infectious conjunctivitis drug-induced conjunctivitis autoimmune keratoconjunctivitis and bacterial conjunctivitis; (2) Systemic or topical ophthalmic use within 1 week prior to treatment that may interfere with the evaluation of the drug's effects; (3) Pregnant or lactating women; (4) Patients who are unable to stop wearing corneal contact lenses during treatment and observation; (5) Patients with mental disorders or those who are unable to communicate normally; (6) Patients with combined hepatic or renal insufficiency immune-related diseases or life-threatening systemic diseases; (7) Those who have taken herbal preparations that can cause allergic rhinitis within 14 days or have contraindications to needling.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eye Symptom Score;Scoring of ocular signs; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood IgE antibody;Tear IgE; | — |
Countries
china
Contacts
Public ContactDuJinyu
Dongzhimen Hospital Beijing University of Traditional Chinese Medicine
Outcome results
None listed